v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 29, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 177,269 $ 250,470
Adjustments to reconcile net income from operations to net cash provided by operating activities:    
Depreciation 52,835 48,927
Stock-based compensation 32,031 30,693
Equity in net earnings of affiliate 11,511 0
Losses (gains) on investments (1,078) 13,090
Provision for excess and obsolete inventory 12,347 9,438
Amortization 8,856 9,397
Gain on sale of business 0 (57,486)
Deferred taxes (14,998) (16,830)
Retirement plan actuarial losses (gains) 127 (250)
Other 3,168 1,240
Changes in operating assets and liabilities, net of businesses acquired:    
Accounts receivable 49,496 (54,211)
Inventories (23,707) 17,102
Prepayments and other assets 30,879 22,190
Accounts payable and other liabilities 17,135 (53,009)
Deferred revenue and customer advances 13,056 2,739
Retirement plans contributions (5,576) (2,774)
Income taxes (19,625) 2,622
Net cash provided by operating activities 343,726 223,348
Cash flows from investing activities:    
Purchases of property, plant and equipment (114,429) (88,869)
Acquisition of businesses, net of cash acquired (144,380) 0
Purchase of investment in a business (5,368) (524,653)
Purchases of marketable securities (17,150) (27,757)
Proceeds from the sale of a business, net of cash and cash equivalents sold 0 87,172
Proceeds from maturities of marketable securities 32,603 26,858
Proceeds from sales of marketable securities 8,487 21,289
Proceeds from insurance 0 873
Net cash used for investing activities (240,237) (505,087)
Cash flows from financing activities:    
Repayments of borrowings on revolving credit facility 0 (185,000)
Dividend payments (38,584) (37,370)
Repurchase of common stock (274,873) (30,306)
Payments related to net settlement of employee stock compensation awards (14,954) (13,434)
Proceeds from borrowings on revolving credit facility 0 185,000
Issuance of common stock under stock purchase and stock option plans 14,792 21,836
Net cash used for financing activities (313,619) (59,274)
Effects of exchange rate changes on cash and cash equivalents (3,972) 5,346
Decrease in cash and cash equivalents (214,102) (335,667)
Cash and cash equivalents at beginning of period 553,354 757,571
Cash and cash equivalents at end of period 339,252 421,904
Non-cash investing activities:    
Capital expenditures incurred but not yet paid: $ 4,722 $ 3,124